Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

News

 

First Patients Enrolled in Pivotal DETOUR II Trial

February 22, 2018 -- PQ Bypass announced enrollment of the first patients in the pivotal DETOUR II trial in the United States. The trial is a prospective, multicenter, si…

EffPac Trial Data for iVascular's Luminor DCB Presented at LINC

February 22, 2018 -- iVascular SLU recently announced that the 6-month results from the EffPac trial were presented by Prof. Dierk Scheinert, MD, at LINC 2018, the Leipzi…

FDA Clears Access Vascular's HydroPICC Catheter

February 22, 2018 -- Access Vascular announced that the company has received 510(k) clearance from the US Food and Drug Administration (FDA) for the HydroPICC, a peripherally …

FDA Clears Corindus' CorPath GRX System in Peripheral Vascular Interventions

February 20, 2018 -- Corindus Vascular Robotics, Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration for use of the company's Cor…

Three Rivers Medical's Rio Embolization Coil System Receives CE Mark Approval

February 20, 2018-Three Rivers Medical, Inc. announced that it has received CE Mark approval for the Rio embolization coil system, which is indicated for endovascular emboliza…

Analysis Suggests Preclinical Safety Studies Should Balance Male/Female Animal Models to Evaluate Sex-Dependent Vascular Responses in Humans

February 20, 2018 -- CBSET, a not-for-profit preclinical research institute, announced that its scientists have published data and analyses that "illustrate differences i…

Click here for more News coverage

Current Supplement

Sponsored by GORE & ASSOCIATES

Meeting the Needs of Complex Peripheral Artery Disease

The devices and decisions needed for optimizing outcomes.

Fall Supplement

Sponsored by BTG INTERNATIONAL

Setting the Standard in VTE

Exploring new data in the treatment of DVT and PE.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $59.72  1.24%
AstraZeneca PLC $34.02  0.96%
Avinger $1.30  -7.80%
Boston Scientific Corporation $27.17  2.59%
Cardinal Health $69.30  2.16%
Cardiovascular Systems Inc. $22.37  2.03%
Edwards Lifesciences Corp. $135.56  1.41%
Endologix Inc. $4.05  0.12%
Johnson and Johnson $132.03  -0.84%
Vascular Market Price  Change
Medtronic, Inc. $80.31  -3.61%
Merit Medical Systems, Inc. $46.65  2.08%
Penumbra, Inc. $102.00  3.34%
Philips $38.97  -0.05%
Stryker $161.66  1.84%
Teleflex Inc. $255.47  -5.05%
The Medicines Company $31.03  -6.44%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.